Skip to main contentSkip to navigationSkip to search

Recursion

Biopharma company mapping and navigating biology and chemistry with the goal of bringing better medicines to patients faster and at lower cost

5%

Kinnevik stake

SEK 1.0bn

Fair value 31 december 2023

See also

More